25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MRK (Merck & Company Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Merck & Company Inc together

I guess you are interested in Merck & Company Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Merck & Company Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Merck & Company Inc’s Price Targets

I'm going to help you getting a better view of Merck & Company Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Merck & Company Inc

I send you an email if I find something interesting about Merck & Company Inc.

1. Quick Overview

1.1. Quick analysis of Merck & Company Inc (30 sec.)










1.2. What can you expect buying and holding a share of Merck & Company Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.88
When do you have the money?
1 year
How often do you get paid?
59.1%

What is your share worth?

Current worth
€68.77
Expected worth in 1 year
€72.96
How sure are you?
68.2%

+ What do you gain per year?

Total Gains per Share
€4.95
Return On Investment
4.3%

For what price can you sell your share?

Current Price per Share
€114.60
Expected price per share
€110.34 - €133.70
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Merck & Company Inc (5 min.)




Live pricePrice per Share (EOD)
€114.60
Intrinsic Value Per Share
€3.12 - €1.63
Total Value Per Share
€71.88 - €70.40

2.2. Growth of Merck & Company Inc (5 min.)




Is Merck & Company Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$34.4b$31.6b$2b6.0%

How much money is Merck & Company Inc making?

Current yearPrevious yearGrowGrow %
Making money$812.2m$784.9m$27.3m3.4%
Net Profit Margin13.2%13.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Merck & Company Inc (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#14 / 200

Most Revenue
#22 / 200

Most Profit
#20 / 200
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Merck & Company Inc?

Welcome investor! Merck & Company Inc's management wants to use your money to grow the business. In return you get a share of Merck & Company Inc.

First you should know what it really means to hold a share of Merck & Company Inc. And how you can make/lose money.

Speculation

The Price per Share of Merck & Company Inc is €114.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Merck & Company Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Merck & Company Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €68.77. Based on the TTM, the Book Value Change Per Share is €1.05 per quarter. Based on the YOY, the Book Value Change Per Share is €1.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.19 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Merck & Company Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps1.951.7%1.871.6%1.811.6%1.941.7%1.891.6%1.591.4%
Usd Book Value Change Per Share-0.24-0.2%1.211.1%1.221.1%1.531.3%1.501.3%3.603.1%
Usd Dividend Per Share0.120.1%0.220.2%0.800.7%0.710.6%0.480.4%0.500.4%
Usd Total Gains Per Share-0.11-0.1%1.431.2%2.021.8%2.232.0%1.981.7%4.113.6%
Usd Price Per Share148.91-167.88-176.65-179.70-181.79-154.57-
Price to Earnings Ratio19.10-22.73-24.58-23.49-24.94-22.28-
Price-to-Total Gains Ratio-1,305.85--374.01-20.47--98.19--134.80--119.78-
Price to Book Ratio1.88-2.17-2.42-2.45-2.88-2.50-
Price-to-Total Gains Ratio-1,305.85--374.01-20.47--98.19--134.80--119.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share132.1338
Number of shares7
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.220.48
Usd Book Value Change Per Share1.211.50
Usd Total Gains Per Share1.431.98
Gains per Quarter (7 shares)10.0013.87
Gains per Year (7 shares)39.9955.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
163430144245
21268702784100
31810211041126155
42513515054168210
53116919068210265
63720323081252320
74323727095294375
849271310108336430
955305350122378485
1061339390135419540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%22.00.00.0100.0%22.00.00.0100.0%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%13.07.00.065.0%15.07.00.068.2%15.07.00.068.2%
Dividend per Share2.00.02.050.0%8.00.04.066.7%11.00.09.055.0%13.00.09.059.1%13.00.09.059.1%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%13.07.00.065.0%15.07.00.068.2%15.07.00.068.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Merck & Company Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2051.049-120%1.060-119%1.324-115%1.299-116%3.126-107%
Book Value Per Share--68.76667.215+2%63.191+9%63.901+8%56.334+22%48.427+42%
Current Ratio--1.3061.286+2%1.437-9%1.348-3%1.222+7%1.183+10%
Debt To Asset Ratio--0.3940.418-6%0.441-11%0.439-10%0.486-19%0.502-21%
Debt To Equity Ratio--0.6530.722-10%0.793-18%0.788-17%0.979-33%1.048-38%
Dividend Per Share--0.1060.190-44%0.692-85%0.614-83%0.419-75%0.436-76%
Enterprise Value--36676562814.55042287908969.675-13%44915655479.863-18%46003882156.608-20%45752954036.000-20%43146629016.811-15%
Eps--1.6911.620+4%1.566+8%1.683+0%1.639+3%1.382+22%
Ev To Sales Ratio--1.7371.985-12%2.159-20%2.141-19%2.218-22%2.105-17%
Free Cash Flow Per Share--0.0741.247-94%1.048-93%1.207-94%1.333-94%1.265-94%
Free Cash Flow To Equity Per Share--0.0741.247-94%1.048-93%1.207-94%1.333-94%1.265-94%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.632----------
Intrinsic Value_10Y_min--3.117----------
Intrinsic Value_1Y_max--4.158----------
Intrinsic Value_1Y_min--4.087----------
Intrinsic Value_3Y_max--9.450----------
Intrinsic Value_3Y_min--9.083----------
Intrinsic Value_5Y_max--11.071----------
Intrinsic Value_5Y_min--10.538----------
Market Cap--56151562814.55063303658969.675-11%66613405479.863-16%67760132156.608-17%68549254036.000-18%58287713534.794-4%
Net Profit Margin--0.1390.132+5%0.131+6%0.136+2%0.139+1%0.128+9%
Operating Margin----0%-0%-0%0.043-100%0.087-100%
Operating Ratio--1.2131.2160%1.253-3%1.2150%1.205+1%1.2150%
Pb Ratio1.667-13%1.8782.172-14%2.424-23%2.451-23%2.883-35%2.496-25%
Pe Ratio16.947-13%19.09922.728-16%24.581-22%23.492-19%24.937-23%22.277-14%
Price Per Share114.600-13%129.150145.600-11%153.213-16%155.850-17%157.665-18%134.063-4%
Price To Free Cash Flow Ratio389.262-13%438.684127.951+243%44.291+890%72.505+505%55.835+686%48.520+804%
Price To Total Gains Ratio-1158.734+11%-1305.850-374.015-71%20.467-6480%-98.192-92%-134.796-90%-119.781-91%
Quick Ratio--0.5210.453+15%0.489+7%0.484+8%0.442+18%0.422+24%
Return On Assets--0.0150.014+6%0.014+8%0.015+1%0.015-1%0.014+8%
Return On Equity--0.0250.024+2%0.025-1%0.026-7%0.030-17%0.028-11%
Total Gains Per Share---0.0991.239-108%1.753-106%1.938-105%1.718-106%3.561-103%
Usd Book Value--34472394000.00033694695500.000+2%31677522000.000+9%32033318583.333+8%28240313700.000+22%26740468240.000+29%
Usd Book Value Change Per Share---0.2361.209-120%1.223-119%1.527-115%1.498-116%3.604-107%
Usd Book Value Per Share--79.28777.499+2%72.859+9%73.677+8%64.953+22%55.836+42%
Usd Dividend Per Share--0.1220.219-44%0.798-85%0.708-83%0.483-75%0.502-76%
Usd Enterprise Value--42288076925.17648757959042.035-13%51787750768.282-18%53042476126.569-20%52753156003.508-20%49748063256.383-15%
Usd Eps--1.9491.868+4%1.805+8%1.941+0%1.889+3%1.593+22%
Usd Free Cash Flow--36896000.000624926000.000-94%525191500.000-93%605036750.000-94%667990550.000-94%626263480.000-94%
Usd Free Cash Flow Per Share--0.0851.437-94%1.208-93%1.392-94%1.536-94%1.459-94%
Usd Free Cash Flow To Equity Per Share--0.0851.437-94%1.208-93%1.392-94%1.536-94%1.459-94%
Usd Market Cap--64742751925.17672989118792.035-11%76805256518.282-16%78127432376.569-17%79037289903.508-18%67205733705.617-4%
Usd Price Per Share132.134-13%148.910167.877-11%176.654-16%179.695-17%181.788-18%154.575-4%
Usd Profit--847455000.000812288500.000+4%784904750.000+8%843803833.333+0%821397200.000+3%739073000.000+15%
Usd Revenue--6087840000.0006144337000.000-1%6001365000.000+1%6193819916.667-2%5909816800.000+3%5674328080.000+7%
Usd Total Gains Per Share---0.1141.428-108%2.021-106%2.235-105%1.981-106%4.106-103%
 EOD+5 -1MRQTTM+17 -20YOY+16 -213Y+15 -225Y+15 -2310Y+17 -21

3.3 Fundamental Score

Let's check the fundamental score of Merck & Company Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.947
Price to Book Ratio (EOD)Between0-11.667
Net Profit Margin (MRQ)Greater than00.139
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.521
Current Ratio (MRQ)Greater than11.306
Debt to Asset Ratio (MRQ)Less than10.394
Debt to Equity Ratio (MRQ)Less than10.653
Return on Equity (MRQ)Greater than0.150.025
Return on Assets (MRQ)Greater than0.050.015
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Merck & Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose114.600
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Merck & Company Inc

  • Other
  • 0

There is no Profile data available for MRK.BE.

Fundamental data was last updated by Penke on 2025-05-29 22:54:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Merck & Company Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Merck & Company Inc to theΒ Other industry mean.
  • A Net Profit Margin of 13.9%Β means thatΒ €0.14 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Merck & Company Inc:

  • The MRQ is 13.9%. The company is making a huge profit. +2
  • The TTM is 13.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.9%TTM13.2%+0.7%
TTM13.2%YOY13.1%+0.2%
TTM13.2%5Y13.9%-0.6%
5Y13.9%10Y12.8%+1.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ13.9%5.5%+8.4%
TTM13.2%5.8%+7.4%
YOY13.1%5.2%+7.9%
3Y13.6%5.8%+7.8%
5Y13.9%5.8%+8.1%
10Y12.8%6.3%+6.5%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Merck & Company Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Merck & Company Inc to theΒ Other industry mean.
  • 1.5% Return on Assets means thatΒ Merck & Company Inc generatedΒ €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Merck & Company Inc:

  • The MRQ is 1.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.4%+0.1%
TTM1.4%YOY1.4%+0.0%
TTM1.4%5Y1.5%-0.1%
5Y1.5%10Y1.4%+0.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%0.8%+0.7%
TTM1.4%0.9%+0.5%
YOY1.4%0.8%+0.6%
3Y1.5%1.0%+0.5%
5Y1.5%0.9%+0.6%
10Y1.4%1.0%+0.4%
4.3.1.3. Return on Equity

Shows how efficient Merck & Company Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Merck & Company Inc to theΒ Other industry mean.
  • 2.5% Return on Equity means Merck & Company Inc generated €0.02Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Merck & Company Inc:

  • The MRQ is 2.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.5%TTM2.4%+0.0%
TTM2.4%YOY2.5%-0.1%
TTM2.4%5Y3.0%-0.6%
5Y3.0%10Y2.8%+0.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5%2.9%-0.4%
TTM2.4%2.4%+0.0%
YOY2.5%2.3%+0.2%
3Y2.6%2.8%-0.2%
5Y3.0%2.9%+0.1%
10Y2.8%2.8%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Merck & Company Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Merck & Company Inc is operatingΒ .

  • Measures how much profit Merck & Company Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Merck & Company Inc to theΒ Other industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Merck & Company Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y4.3%-4.3%
5Y4.3%10Y8.7%-4.3%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.2%-11.2%
TTM-10.0%-10.0%
YOY-7.3%-7.3%
3Y-2.7%-2.7%
5Y4.3%2.8%+1.5%
10Y8.7%5.4%+3.3%
4.3.2.2. Operating Ratio

Measures how efficient Merck & Company Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Other industry mean).
  • An Operation Ratio of 1.21 means that the operating costs are €1.21 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Merck & Company Inc:

  • The MRQ is 1.213. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.216. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.213TTM1.216-0.002
TTM1.216YOY1.253-0.037
TTM1.2165Y1.205+0.010
5Y1.20510Y1.215-0.010
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2131.479-0.266
TTM1.2161.498-0.282
YOY1.2531.515-0.262
3Y1.2151.530-0.315
5Y1.2051.515-0.310
10Y1.2151.490-0.275
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Merck & Company Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Merck & Company Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Other industry mean).
  • A Current Ratio of 1.31Β means the company has €1.31 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Merck & Company Inc:

  • The MRQ is 1.306. The company is just able to pay all its short-term debts.
  • The TTM is 1.286. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.306TTM1.286+0.021
TTM1.286YOY1.437-0.152
TTM1.2865Y1.222+0.064
5Y1.22210Y1.183+0.039
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3061.408-0.102
TTM1.2861.380-0.094
YOY1.4371.534-0.097
3Y1.3481.511-0.163
5Y1.2221.577-0.355
10Y1.1831.518-0.335
4.4.3.2. Quick Ratio

Measures if Merck & Company Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Merck & Company Inc to theΒ Other industry mean.
  • A Quick Ratio of 0.52Β means the company can pay off €0.52 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Merck & Company Inc:

  • The MRQ is 0.521. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.453. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.521TTM0.453+0.069
TTM0.453YOY0.489-0.036
TTM0.4535Y0.442+0.011
5Y0.44210Y0.422+0.020
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5210.493+0.028
TTM0.4530.461-0.008
YOY0.4890.521-0.032
3Y0.4840.498-0.014
5Y0.4420.527-0.085
10Y0.4220.555-0.133
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Merck & Company Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Merck & Company IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Merck & Company Inc to Other industry mean.
  • A Debt to Asset Ratio of 0.39Β means that Merck & Company Inc assets areΒ financed with 39.4% credit (debt) and the remaining percentage (100% - 39.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Merck & Company Inc:

  • The MRQ is 0.394. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.418. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.394TTM0.418-0.024
TTM0.418YOY0.441-0.023
TTM0.4185Y0.486-0.068
5Y0.48610Y0.502-0.017
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3940.528-0.134
TTM0.4180.537-0.119
YOY0.4410.536-0.095
3Y0.4390.540-0.101
5Y0.4860.550-0.064
10Y0.5020.559-0.057
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Merck & Company Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Merck & Company Inc to theΒ Other industry mean.
  • A Debt to Equity ratio of 65.3% means that company has €0.65 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Merck & Company Inc:

  • The MRQ is 0.653. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.722. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.653TTM0.722-0.069
TTM0.722YOY0.793-0.071
TTM0.7225Y0.979-0.257
5Y0.97910Y1.048-0.069
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6531.174-0.521
TTM0.7221.174-0.452
YOY0.7931.199-0.406
3Y0.7881.226-0.438
5Y0.9791.378-0.399
10Y1.0481.431-0.383
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Merck & Company Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Merck & Company Inc to theΒ Other industry mean.
  • A PE ratio of 19.10 means the investor is paying €19.10Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Merck & Company Inc:

  • The EOD is 16.947. Based on the earnings, the company is fair priced.
  • The MRQ is 19.099. Based on the earnings, the company is fair priced.
  • The TTM is 22.728. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD16.947MRQ19.099-2.152
MRQ19.099TTM22.728-3.629
TTM22.728YOY24.581-1.853
TTM22.7285Y24.937-2.209
5Y24.93710Y22.277+2.660
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD16.94713.952+2.995
MRQ19.09913.998+5.101
TTM22.72813.192+9.536
YOY24.58110.542+14.039
3Y23.4929.757+13.735
5Y24.93712.133+12.804
10Y22.27711.200+11.077
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Merck & Company Inc:

  • The EOD is 389.262. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 438.684. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 127.951. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD389.262MRQ438.684-49.422
MRQ438.684TTM127.951+310.733
TTM127.951YOY44.291+83.660
TTM127.9515Y55.835+72.116
5Y55.83510Y48.520+7.314
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD389.2628.403+380.859
MRQ438.6847.596+431.088
TTM127.9517.171+120.780
YOY44.2914.811+39.480
3Y72.5050.251+72.254
5Y55.8353.615+52.220
10Y48.5203.395+45.125
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Merck & Company Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Other industry mean).
  • A PB ratio of 1.88 means the investor is paying €1.88Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Merck & Company Inc:

  • The EOD is 1.667. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.878. Based on the equity, the company is underpriced. +1
  • The TTM is 2.172. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.667MRQ1.878-0.212
MRQ1.878TTM2.172-0.294
TTM2.172YOY2.424-0.252
TTM2.1725Y2.883-0.712
5Y2.88310Y2.496+0.388
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD1.6671.283+0.384
MRQ1.8781.244+0.634
TTM2.1721.329+0.843
YOY2.4241.344+1.080
3Y2.4511.328+1.123
5Y2.8831.641+1.242
10Y2.4961.638+0.858
4.6.2. Total Gains per Share

2.4. Latest News of Merck & Company Inc

Does Merck & Company Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Merck & Company Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-05-26
17:25
SpringWorks Gets CHMP Nod for Mirdametinib in Rare DiseaseRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets49,373,000
Total Liabilities19,475,000
Total Stockholder Equity29,823,000
 As reported
Total Liabilities 19,475,000
Total Stockholder Equity+ 29,823,000
Total Assets = 49,373,000

Assets

Total Assets49,373,000
Total Current Assets12,412,000
Long-term Assets36,961,000
Total Current Assets
Cash And Cash Equivalents 1,005,000
Short-term Investments 615,000
Net Receivables 4,339,000
Inventory 4,513,000
Other Current Assets 702,000
Total Current Assets  (as reported)12,412,000
Total Current Assets  (calculated)11,174,000
+/- 1,238,000
Long-term Assets
Property Plant Equipment 9,854,000
Goodwill 18,575,000
Intangible Assets 5,981,000
Long-term Assets Other 107,000
Long-term Assets  (as reported)36,961,000
Long-term Assets  (calculated)34,517,000
+/- 2,444,000

Liabilities & Shareholders' Equity

Total Current Liabilities9,502,000
Long-term Liabilities9,973,000
Total Stockholder Equity29,823,000
Total Current Liabilities
Accounts payable 2,092,000
Other Current Liabilities 1,580,000
Total Current Liabilities  (as reported)9,502,000
Total Current Liabilities  (calculated)3,672,000
+/- 5,830,000
Long-term Liabilities
Long-term Liabilities Other 11,000
Long-term Liabilities  (as reported)9,973,000
Long-term Liabilities  (calculated)11,000
+/- 9,962,000
Total Stockholder Equity
Retained Earnings 22,980,000
Total Stockholder Equity (as reported)29,823,000
Total Stockholder Equity (calculated)22,980,000
+/- 6,843,000
Other
Capital Stock565,000
Common Stock Shares Outstanding 434,778
Net Invested Capital 29,823,000
Net Working Capital 2,910,000



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
38,717,000
39,568,000
42,067,000
43,811,000
44,743,000
43,822,000
43,231,000
41,796,000
43,891,000
43,145,000
43,836,000
45,362,000
46,235,000
48,717,000
50,933,000
48,535,000
48,637,000
48,782,000
49,906,000
48,495,000
49,504,000
49,875,000
50,142,000
51,567,000
49,373,000
49,373,00051,567,00050,142,00049,875,00049,504,00048,495,00049,906,00048,782,00048,637,00048,535,00050,933,00048,717,00046,235,00045,362,00043,836,00043,145,00043,891,00041,796,00043,231,00043,822,00044,743,00043,811,00042,067,00039,568,00038,717,000
   > Total Current Assets 
10,512,000
11,694,000
13,518,000
9,003,000
10,013,000
9,726,000
10,258,000
9,280,000
10,617,000
10,182,000
10,315,000
10,982,000
11,085,000
12,416,000
12,943,000
12,201,000
12,951,000
13,019,000
13,566,000
12,393,000
12,823,000
13,047,000
13,929,000
13,450,000
12,412,000
12,412,00013,450,00013,929,00013,047,00012,823,00012,393,00013,566,00013,019,00012,951,00012,201,00012,943,00012,416,00011,085,00010,982,00010,315,00010,182,00010,617,0009,280,00010,258,0009,726,00010,013,0009,003,00013,518,00011,694,00010,512,000
       Cash And Cash Equivalents 
2,340,000
3,451,000
5,111,000
541,000
1,530,000
1,512,000
1,548,000
1,110,000
2,238,000
1,825,000
1,523,000
1,511,000
1,339,000
1,580,000
1,604,000
1,398,000
1,584,000
1,761,000
2,365,000
1,578,000
2,220,000
2,685,000
3,161,000
2,149,000
1,005,000
1,005,0002,149,0003,161,0002,685,0002,220,0001,578,0002,365,0001,761,0001,584,0001,398,0001,604,0001,580,0001,339,0001,511,0001,523,0001,825,0002,238,0001,110,0001,548,0001,512,0001,530,000541,0005,111,0003,451,0002,340,000
       Short-term Investments 
64,000
154,000
275,000
29,000
81,000
32,000
85,000
29,000
691,000
45,000
142,000
112,000
106,000
133,000
347,000
244,000
1,653,000
166,000
218,000
431,000
264,000
130,000
699,000
558,000
615,000
615,000558,000699,000130,000264,000431,000218,000166,0001,653,000244,000347,000133,000106,000112,000142,00045,000691,00029,00085,00032,00081,00029,000275,000154,00064,000
       Net Receivables 
3,616,000
3,468,000
3,440,000
3,488,000
3,690,000
3,509,000
3,487,000
3,221,000
3,654,000
3,657,000
3,753,000
3,646,000
4,138,000
4,414,000
4,346,000
4,114,000
4,270,000
4,210,000
4,195,000
4,004,000
4,147,000
4,263,000
3,988,000
3,947,000
4,339,000
4,339,0003,947,0003,988,0004,263,0004,147,0004,004,0004,195,0004,210,0004,270,0004,114,0004,346,0004,414,0004,138,0003,646,0003,753,0003,657,0003,654,0003,221,0003,487,0003,509,0003,690,0003,488,0003,440,0003,468,0003,616,000
       Inventory 
2,937,000
3,033,000
3,135,000
3,342,000
3,443,000
3,537,000
3,428,000
3,294,000
3,462,000
3,564,000
3,760,000
3,900,000
4,143,000
4,474,000
4,860,000
4,632,000
4,890,000
4,996,000
4,971,000
4,637,000
4,716,000
4,714,000
4,405,000
4,484,000
4,513,000
4,513,0004,484,0004,405,0004,714,0004,716,0004,637,0004,971,0004,996,0004,890,0004,632,0004,860,0004,474,0004,143,0003,900,0003,760,0003,564,0003,462,0003,294,0003,428,0003,537,0003,443,0003,342,0003,135,0003,033,0002,937,000
       Other Current Assets 
1,126,000
1,284,000
1,232,000
97,000
553,000
585,000
1,099,000
76,000
0
624,000
683,000
94,000
792,000
1,362,000
1,336,000
151,000
-1,000
1,250,000
1,141,000
127,000
942,000
673,000
622,000
143,000
702,000
702,000143,000622,000673,000942,000127,0001,141,0001,250,000-1,000151,0001,336,0001,362,000792,00094,000683,000624,000076,0001,099,000585,000553,00097,0001,232,0001,284,0001,126,000
   > Long-term Assets 
28,204,000
27,874,000
28,550,000
34,808,000
34,730,000
34,096,000
32,973,000
32,516,000
33,273,000
32,963,000
33,521,000
34,380,000
35,149,000
36,301,000
37,990,000
36,334,000
35,686,000
35,763,000
36,340,000
36,102,000
36,681,000
36,828,000
36,213,000
38,116,000
36,961,000
36,961,00038,116,00036,213,00036,828,00036,681,00036,102,00036,340,00035,763,00035,686,00036,334,00037,990,00036,301,00035,149,00034,380,00033,521,00032,963,00033,273,00032,516,00032,973,00034,096,00034,730,00034,808,00028,550,00027,874,00028,204,000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,946,000
8,204,000
8,218,000
8,393,000
8,719,000
9,056,000
9,214,000
9,433,000
9,415,000
10,025,000
9,854,000
9,854,00010,025,0009,415,0009,433,0009,214,0009,056,0008,719,0008,393,0008,218,0008,204,0007,946,00000000000000000
       Goodwill 
13,966,000
13,841,000
14,309,000
17,141,000
17,376,000
17,118,000
16,512,000
15,959,000
16,541,000
16,347,000
16,670,000
17,004,000
17,761,000
18,573,000
19,534,000
18,389,000
18,077,000
18,102,000
18,466,000
17,845,000
18,181,000
18,321,000
18,093,000
19,152,000
18,575,000
18,575,00019,152,00018,093,00018,321,00018,181,00017,845,00018,466,00018,102,00018,077,00018,389,00019,534,00018,573,00017,761,00017,004,00016,670,00016,347,00016,541,00015,959,00016,512,00017,118,00017,376,00017,141,00014,309,00013,841,00013,966,000
       Intangible Assets 
7,052,000
6,770,000
6,730,000
9,175,000
9,089,000
8,664,000
8,172,000
7,653,000
7,765,000
7,613,000
7,628,000
7,612,000
7,549,000
7,862,000
8,080,000
7,335,000
6,954,000
6,765,000
6,716,000
6,552,000
6,481,000
6,208,000
5,845,000
6,282,000
5,981,000
5,981,0006,282,0005,845,0006,208,0006,481,0006,552,0006,716,0006,765,0006,954,0007,335,0008,080,0007,862,0007,549,0007,612,0007,628,0007,613,0007,765,0007,653,0008,172,0008,664,0009,089,0009,175,0006,730,0006,770,0007,052,000
       Long-term Assets Other 
81,000
87,000
91,000
80,000
94,000
91,000
91,000
62,000
84,000
87,000
84,000
74,000
104,000
99,000
104,000
68,000
99,000
89,000
98,000
75,000
138,000
133,000
127,000
90,000
107,000
107,00090,000127,000133,000138,00075,00098,00089,00099,00068,000104,00099,000104,00074,00084,00087,00084,00062,00091,00091,00094,00080,00091,00087,00081,000
> Total Liabilities 
21,042,000
21,994,000
23,885,000
25,898,000
26,143,000
25,796,000
25,236,000
24,779,000
24,908,000
23,784,000
23,157,000
23,946,000
23,245,000
22,688,000
22,596,000
22,530,000
22,407,000
22,010,000
21,611,000
21,740,000
21,430,000
21,259,000
21,749,000
21,580,000
19,475,000
19,475,00021,580,00021,749,00021,259,00021,430,00021,740,00021,611,00022,010,00022,407,00022,530,00022,596,00022,688,00023,245,00023,946,00023,157,00023,784,00024,908,00024,779,00025,236,00025,796,00026,143,00025,898,00023,885,00021,994,00021,042,000
   > Total Current Liabilities 
11,194,000
10,494,000
9,655,000
11,842,000
10,764,000
10,080,000
9,709,000
9,231,000
10,652,000
9,820,000
9,793,000
10,432,000
10,207,000
9,718,000
9,412,000
9,514,000
9,556,000
8,846,000
8,685,000
8,699,000
9,939,000
9,931,000
10,463,000
11,294,000
9,502,000
9,502,00011,294,00010,463,0009,931,0009,939,0008,699,0008,685,0008,846,0009,556,0009,514,0009,412,0009,718,00010,207,00010,432,0009,793,0009,820,00010,652,0009,231,0009,709,00010,080,00010,764,00011,842,0009,655,00010,494,00011,194,000
       Short-term Debt 
0
0
0
4,423,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000004,423,000000
       Short Long Term Debt 
0
0
0
4,423,000
0
0
0
2,182,000
0
0
0
2,379,000
0
0
0
1,073,000
0
0
0
503,000
0
0
0
3,136,000
0
03,136,000000503,0000001,073,0000002,379,0000002,182,0000004,423,000000
       Accounts payable 
1,633,000
1,737,000
1,736,000
2,054,000
1,807,000
1,764,000
1,684,000
1,768,000
1,937,000
2,107,000
2,132,000
1,542,000
2,356,000
2,456,000
2,445,000
1,596,000
2,326,000
2,403,000
2,244,000
1,770,000
2,086,000
2,122,000
1,950,000
1,502,000
2,092,000
2,092,0001,502,0001,950,0002,122,0002,086,0001,770,0002,244,0002,403,0002,326,0001,596,0002,445,0002,456,0002,356,0001,542,0002,132,0002,107,0001,937,0001,768,0001,684,0001,764,0001,807,0002,054,0001,736,0001,737,0001,633,000
       Other Current Liabilities 
1,863,000
1,629,000
1,688,000
564,000
1,852,000
1,718,000
1,983,000
666,000
2,277,000
2,052,000
2,239,000
839,000
2,417,000
2,297,000
2,474,000
1,000
2,756,000
1,489,000
1,619,000
0
1,607,000
1,385,000
1,518,000
0
1,580,000
1,580,00001,518,0001,385,0001,607,00001,619,0001,489,0002,756,0001,0002,474,0002,297,0002,417,000839,0002,239,0002,052,0002,277,000666,0001,983,0001,718,0001,852,000564,0001,688,0001,629,0001,863,000
   > Long-term Liabilities 
9,848,000
11,500,000
14,230,000
14,056,000
15,379,000
15,716,000
15,527,000
15,548,000
14,256,000
13,964,000
13,364,000
13,514,000
13,038,000
12,970,000
13,184,000
13,016,000
12,851,000
13,164,000
12,926,000
13,041,000
11,491,000
11,328,000
11,286,000
10,286,000
9,973,000
9,973,00010,286,00011,286,00011,328,00011,491,00013,041,00012,926,00013,164,00012,851,00013,016,00013,184,00012,970,00013,038,00013,514,00013,364,00013,964,00014,256,00015,548,00015,527,00015,716,00015,379,00014,056,00014,230,00011,500,0009,848,000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-3,856,000
0
0
0
439,000
0
0
0
459,000
0
0
0
491,000
0
0
0
515,000
0
0
0
762,000
0
0762,000000515,000000491,000000459,000000439,000000-3,856,000000
       Long-term Liabilities Other 
227,000
226,000
225,000
2,000
91,000
88,000
111,000
-1,000
40,000
30,000
15,000
0
15,000
16,000
17,000
2,000
21,000
20,000
18,000
1,000
15,000
12,000
12,000
1,000
11,000
11,0001,00012,00012,00015,0001,00018,00020,00021,0002,00017,00016,00015,000015,00030,00040,000-1,000111,00088,00091,0002,000225,000226,000227,000
> Total Stockholder Equity
17,640,000
17,550,000
18,158,000
17,865,000
18,556,000
17,982,000
17,928,000
16,946,000
18,916,000
19,293,000
20,607,000
21,338,000
22,919,000
25,955,000
28,260,000
25,927,000
26,149,000
26,701,000
28,222,000
26,680,000
27,996,000
28,549,000
28,323,000
29,912,000
29,823,000
29,823,00029,912,00028,323,00028,549,00027,996,00026,680,00028,222,00026,701,00026,149,00025,927,00028,260,00025,955,00022,919,00021,338,00020,607,00019,293,00018,916,00016,946,00017,928,00017,982,00018,556,00017,865,00018,158,00017,550,00017,640,000
   Common Stock0000000000000000000000000
   Retained Earnings 
11,294,000
11,410,000
11,314,000
11,507,000
11,978,000
11,753,000
12,581,000
12,378,000
13,511,000
14,134,000
14,955,000
15,134,000
16,450,000
18,015,000
18,825,000
18,463,000
19,250,000
19,760,000
20,711,000
20,228,000
21,031,000
21,379,000
22,145,000
22,086,000
22,980,000
22,980,00022,086,00022,145,00021,379,00021,031,00020,228,00020,711,00019,760,00019,250,00018,463,00018,825,00018,015,00016,450,00015,134,00014,955,00014,134,00013,511,00012,378,00012,581,00011,753,00011,978,00011,507,00011,314,00011,410,00011,294,000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 0000000000000000000000000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue21,156,000
Cost of Revenue-8,671,000
Gross Profit12,485,00012,485,000
 
Operating Income (+$)
Gross Profit12,485,000
Operating Expense-17,138,000
Operating Income4,018,000-4,653,000
 
Operating Expense (+$)
Research Development2,279,000
Selling General Administrative5,360,000
Selling And Marketing Expenses0
Operating Expense17,138,0007,639,000
 
Net Interest Income (+$)
Interest Income164,000
Interest Expense-292,000
Other Finance Cost-11,000
Net Interest Income-139,000
 
Pretax Income (+$)
Operating Income4,018,000
Net Interest Income-139,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)3,536,0004,018,000
EBIT - interestExpense = -292,000
2,777,000
3,069,000
Interest Expense292,000
Earnings Before Interest and Taxes (EBIT)03,828,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax3,536,000
Tax Provision-751,000
Net Income From Continuing Ops2,785,0002,785,000
Net Income2,777,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0139,000
 

Technical Analysis of Merck & Company Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Merck & Company Inc. The general trend of Merck & Company Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Merck & Company Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Merck & Company Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Merck & Company Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 125.50 < 129.48 < 133.70.

The bearish price targets are: 114.50 > 114.25 > 110.34.

Know someone who trades $MRK? Share this with them.πŸ‘‡

Merck & Company Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Merck & Company Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Merck & Company Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Merck & Company Inc.

Merck & Company Inc Daily Moving Average Convergence/Divergence (MACD) ChartMerck & Company Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Merck & Company Inc. The current adx is .

Merck & Company Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Merck & Company Inc.

Merck & Company Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Merck & Company Inc.

Merck & Company Inc Daily Relative Strength Index (RSI) ChartMerck & Company Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Merck & Company Inc.

Merck & Company Inc Daily Stochastic Oscillator ChartMerck & Company Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Merck & Company Inc.

Merck & Company Inc Daily Commodity Channel Index (CCI) ChartMerck & Company Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Merck & Company Inc.

Merck & Company Inc Daily Chande Momentum Oscillator (CMO) ChartMerck & Company Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Merck & Company Inc.

Merck & Company Inc Daily Williams %R ChartMerck & Company Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Merck & Company Inc.

Merck & Company Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Merck & Company Inc.

Merck & Company Inc Daily Average True Range (ATR) ChartMerck & Company Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Merck & Company Inc.

Merck & Company Inc Daily On-Balance Volume (OBV) ChartMerck & Company Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Merck & Company Inc.

Merck & Company Inc Daily Money Flow Index (MFI) ChartMerck & Company Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Merck & Company Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Merck & Company Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Merck & Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose114.600
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Merck & Company Inc with someone you think should read this too:
  • Are you bullish or bearish on Merck & Company Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Merck & Company Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Merck & Company Inc

I send you an email if I find something interesting about Merck & Company Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Merck & Company Inc.

Receive notifications about Merck & Company Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.